Market Place
Sourcing Support
Qilu Pharma`s Generics Icosapent Ethyl Receives Approval in US
20 Nov 2024 //
FDA
Qilu Pharma`s Generics Bumetanide Receives Approval in US
19 Sep 2024 //
FDA
Qilu Pharmaceutical`s Generics Sugammadex Receives Tentative Approval in US
28 Aug 2024 //
FDA
Qilu`s Generics Meropenem Receives Approval in US
22 Jul 2024 //
FDA
Qilu`s 3 Cancer Immunotherapy Studies At ASCO 2024
06 Jun 2024 //
PR NEWSWIRE
Qilu Pharma`s Generic Cetrorelix Acetate Receives Approval in the U.S
16 Apr 2024 //
FDA
Qilu Pharma Spesolimab-sbzo Receives Suppl Approval in the U.S
19 Mar 2024 //
FDA
Qilu Pharma Showcases QL1706 Clinical Trial Outcomes in Oral Presentation
15 Mar 2024 //
PR NEWSWIRE
Results from Trial of Qilu`s Anticancer Agent QL1706 Featured in Presentation
04 Mar 2024 //
PR NEWSWIRE
Qilu`s Generic Lenalidomide Receives Approval in the U.S.
22 Feb 2024 //
FDA
Results of Phase II Study on Qilu Pharmaceutical`s Novel Drug QL1706 Published
02 Feb 2024 //
PR NEWSWIRE
Results of the Phase III Study on Qilu Pharmaceutical`s Iruplinalkib Published
30 Jan 2024 //
PR NEWSWIRE
Qilu Pharmaceutical Announces Results from Phase I Clinical Study for QLS31905
11 Dec 2023 //
PR NEWSWIRE
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab
06 Dec 2023 //
PR NEWSWIRE
Phase I Results for Qilu Pharmaceutical`s Iparomlimab (QL1604) Now Published
06 Nov 2023 //
PR NEWSWIRE
Qilu Pharmaceutical announces latest results from its clinical study on QL1706
25 Oct 2023 //
PR NEWSWIRE
Qilu Pharma to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023
19 Oct 2023 //
PR NEWSWIRE
QiLu Pharmaceutical`s Iruplinalkib Phase III Study Researched Primary Endpoint
17 Aug 2023 //
PR NEWSWIRE
FDA allows more imports of key cancer med from China`s Qilu
13 Jul 2023 //
FIERCE PHARMA
FDA to import more of cancer drug from China
12 Jul 2023 //
ENDPTS
Qilu Announces Trials in Progress Posters on QL1706 in Phase III
08 Jun 2023 //
PR NEWSWIRE
Advances of Qilu Pharmaceutical`s QL1706 in Clinical Research Presented at ASCO
31 May 2023 //
PR NEWSWIRE
Results of PhI Study of Qilu Pharma`s PD-1/CTLA-4 Iparomlimab/Tuvonralimab
11 May 2023 //
PR NEWSWIRE
Qilu`s Generic Gefitinib Receives Approval in the U.S.
13 Feb 2023 //
FDA
Qilu Pharma Latest Results of QL1604 plus Chemotherapy as First-Line Treatment
05 Dec 2022 //
BIOSPACE
CellOrigin Announces Collaboration with Qilu to Develop CAR-iMAC Cell Therapy
26 Sep 2022 //
PRNEWSWIRE
CellOrigin announced collaboration with Qilu to develop CAR-iMAC cell therapy
06 Sep 2022 //
WFMZ
Qilu Pharmaceutical`s Generic Imatinib Mesylate Receives Approval in US
21 Jun 2022 //
FDA
Qilu Pharm Generic Pemetrexed Disodium Receives Approval in the U.S.
25 May 2022 //
FDA
Qilu Pharmaceutical Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Qilu`s Generic Imatinib Mesylate Receives Approval in the U.S.
11 Feb 2022 //
FDA
Qilu Pharm`s Generic Pemetrexed Receives Approval in the U.S.
28 Jan 2022 //
FDA
S. Korea`s Peptron licenses global development of ADCs for cancer treatment
19 Apr 2021 //
BIOSPECTRUMASIA
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
16 Apr 2021 //
PRNEWSWIRE
Qilu`s Generic Decitabine Receives Approval In US
16 Apr 2021 //
FDA
Sesen Bio and Qilu Pharmaceutical Announce Approval of IND Application Vicineum™
22 Mar 2021 //
BUSINESSWIRE
Cend Therapeutics and Qilu Pharmaceutical Announce Partnership
16 Feb 2021 //
GLOBENEWSWIRE
Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum™
13 Jan 2021 //
BUSINESSWIRE
Sesen Bio and Qilu Announce IND Application for Vicineum™
13 Jan 2021 //
BUSINESSWIRE
Qilu`s Generic Fosaprepitant Dimeglumine Receives Approval In US
08 Sep 2020 //
FDA
Sesen Bio announces an exclusive license agreement with Qilu Pharma
30 Jul 2020 //
BUSINESSWIRE
Qilu Pharm`s Generic Exemestane Receives Approval in US
16 Apr 2020 //
FDA
Indian generics contenders; Chi-Med`s HK listing; Qilu Pharma explosion
20 Apr 2019 //
FIERCE PHARMA
Qilu Pharm`s Generic Tadalafil Receives Approval in US
28 Mar 2019 //
FDA
Qilu Pharm`s Generic Solifenacin Succinate Receives Tentative Approval in US
21 Dec 2018 //
FDA
Cialis (tadalafil) : Eli Lilly vs. Qilu Pharm Co., Ltd.
20 Dec 2018 //
PATENT LITIGATION
Qilu Pharm`s Generic Tadalafil Receives Approval in US
08 Nov 2018 //
FDA
Qilu Pharm`s Generic Ceftriaxone Sodium Receives Approval in US
24 Oct 2018 //
FDA
Qilu Pharm`s Generic Cefazolin Sodium Receives Approval in US
24 Oct 2018 //
FDA
Qilu Pharma`s Generic Palonosetron Hydrochloride Receives Approval in US
21 Sep 2018 //
FDA
Qilu Pharm’s Generic Premetrexed Receives Tentative Approval In US
19 May 2017 //
FDA
Generic version of AZ’s Iressa launched in China
22 Feb 2017 //
PMLIVE
Qilu Pharm Co Ltd`s Generic Oxaliplatin approved in US as chemotherapy drug
11 May 2016 //
FDA
Camptosar ANDA Approval Adds More Competition for Generic Market
09 May 2016 //
TWOFOUR INSIGHT
China`s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts
09 Mar 2016 //
BLOOMBERG
Qilu Pharm`s Generic Olanzapine approved in US as an atypical antipsychotic
27 Jan 2016 //
FDA
